StatStrip Glucose Hospital Meter System

FDA 510(k) K232075 · Nova Biomedical Corporation

Substantially Equivalent

510(k) numberK232075

Submission

Device name
StatStrip Glucose Hospital Meter System
Applicant
Nova Biomedical Corporation
Walham, MA, US
Received
July 12, 2023
Decision date
February 23, 2024
Decision
Substantially Equivalent (SESE)
Type
Dual Track 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PZI – Prescription Use Blood Glucose Meter For Near-Patient Testing
Device class
Class II (moderate risk)
Regulation
21 CFR 862.1345
Specialty
Clinical Chemistry

Intended for use in near-patient testing settings for in vitro diagnostic, multiple-patient use for the quantitative determination of glucose throughout all hospital and all professional healthcare settings for use in determining dysglycemia.

Other 510(k)s with product code PZI

510(k)DeviceApplicantDecision
K252323cobas pulse blood glucose monitoring systemPZI · Dual Track Roche Diagnostics06/12/2026SE
K221349XPER Technology PREMIUM Pro Blood Glucose Monitoring SystemPZI · Dual Track Taidoc Technology Corporation11/19/2024SE
K220272cobas pulse blood glucose monitoring systemPZI · Dual Track Roche Diagnostics04/26/2024SE
K200788Assure Titanium Blood Glucose Monitoring SystemPZI · Dual Track Arkray, Inc.05/23/2022SE
K182552StatStrip Xpress Glucose Hospital Meter SystemPZI · Dual Track Nova Biomedical Corporation12/13/2018SE
K182549StatStrip Xpress 2 Glucose Hospital Meter SystemPZI · Dual Track Nova Biomedical Corporation12/13/2018SE
K181043StatStrip Glucose Hospital Meter SystemPZI · Dual Track Nova Biomedical Corporation07/12/2018SE
K163490StatStrip Xpress 2 Glucose Hospital Meter SystemPZI · Special Nova Biomedical Corporation01/06/2017SE
K161856StatStrip Xpress Glucose Hospital Meter SystemPZI · Special Nova Biomedical Corporation11/15/2016SE
K152986StatStrip Xpress 2 Glucose Hospital Meter SystemPZI · Special Nova Biomedical Corporation01/27/2016SE

More from Nova Biomedical Corporation

510(k)DeviceDecision
K251281Nova Max Creat eGFR Monitoring SystemSHB · Traditional 01/21/2026SE
K252206Nova Allegro UACR Assay, Nova Allegro AnalyzerCGX · Dual Track 01/09/2026SE
K221326Nova Allegro HbA1c Assay, Nova Allegro AnalyzerLCP · Dual Track 11/22/2024SE
K221813Nova Allegro UACR Assay, Nova Allegro AnalyzerCGX · Dual Track 11/19/2024SE
K221900Stat Profile Prime Plus Analyzer SystemCHL · Traditional 09/29/2023SE
K203549Nova Primary Glucose Analyzer SystemCGA · Traditional 10/18/2022SE
K200403Stat Profile Prime Plus Analyzer SystemJGS · Traditional 04/14/2020SE
K200204Stat Profile Prime Plus Analyzer SystemGGZ · Traditional 04/06/2020SE
K200349Stat Profile Prime Plus Analyzer SystemCGA · Traditional 03/13/2020SE
K193246Stat Profile Prime Plus Analyzer SystemCHL · Traditional 01/24/2020SE

Questions and answers

When was StatStrip Glucose Hospital Meter System cleared by the FDA?

StatStrip Glucose Hospital Meter System (K232075) received a 510(k) decision of Substantially Equivalent on February 23, 2024, 226 days after the submission was received.

What is the product code of K232075?

The FDA product code is PZI – Prescription Use Blood Glucose Meter For Near-Patient Testing, a Class II (moderate risk) device regulated under 21 CFR 862.1345.